AbbVie
ABBV
#35
Rank
$240.27 B
Marketcap
$136.19
Share price
-1.00%
Change (1 day)
-7.59%
Change (1 year)

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

Market capitalization of AbbVie (ABBV)

Market cap: $240.27 Billion

As of May 2023 AbbVie has a market cap of $240.27 Billion. This makes AbbVie the world's 35th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of AbbVie from 2012 to 2023

End of year Market Cap

Year Market cap Change
2023$240.27 B-15.93%
2022$285.80 B19.4%
2021$239.37 B26.54%
2020$189.17 B44.47%
2019$130.94 B-3.95%
2018$136.33 B-11.7%
2017$154.39 B51.71%
2016$101.76 B6.7%
2015$95.37 B-8.42%
2014$104.14 B24.23%
2013$83.82 B55.32%
2012$53.97 B

End of Day market cap according to different sources

On May 29th, 2023 the market cap of AbbVie was reported to be:

$242.69 Billion
by Yahoo Finance
$242.69 Billion
by CompaniesMarketCap
$242.67 Billion
by Nasdaq
$242.69 Billion
by Iex Cloud

Market capitalization for similar companies or competitors

Name Market cap Market cap differencediff. Country
$209.80 B-12.68%๐Ÿ‡บ๐Ÿ‡ธ USA
$406.06 B 69.00%๐Ÿ‡บ๐Ÿ‡ธ USA
$116.90 B-51.35%๐Ÿ‡บ๐Ÿ‡ธ USA
$43.21 B-82.02%๐Ÿ‡บ๐Ÿ‡ธ USA
$95.53 B-60.24%๐Ÿ‡บ๐Ÿ‡ธ USA
$133.88 B-44.28%๐Ÿ‡บ๐Ÿ‡ธ USA
$221.70 B-7.73%๐Ÿ‡ฌ๐Ÿ‡ง UK
$69.27 B-71.17%๐Ÿ‡ฌ๐Ÿ‡ง UK
$8.72 B-96.37%๐Ÿ‡บ๐Ÿ‡ธ USA